Related Experiment Video
Updated: May 7, 2026

10:19
A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
14.3K
Invasive Group A Streptococcus Hypervirulent M1UK Clone, Canada, 2018-2023
Emerging Infectious Diseases
|October 20, 2024
Summary
Invasive group A Streptococcus trends in Canada show a significant rise in hypervirulent M1 lineage isolates. Genomic analysis revealed geographic clusters and genes linked to bacteriophage acquisition.
Area of Science:
- Microbiology
- Infectious Diseases
- Genomics
Background:
- Group A Streptococcus (GAS) is a significant pathogen causing various infections.
- The emm1 serotype is a common cause of invasive GAS disease.
- Monitoring trends of specific GAS lineages is crucial for public health.
Purpose of the Study:
- To investigate the epidemiological trends of invasive emm1 group A Streptococcus in Canada.
- To characterize the genetic features of emm1 isolates over a defined period.
Main Methods:
- Collection and characterization of emm1 Streptococcus isolates from 2018 to 2023.
- Analysis of isolate data to determine temporal and geographic trends.
- Genomic sequencing to identify genetic elements and lineage-specific features.
Main Results:
- A significant increase in the proportion of hypervirulent M1UK lineage emm1 isolates was observed, rising from 22.1% in 2018 to 60.2% in 2023.
- Genomic analysis identified distinct geographically and temporally associated clusters of emm1 isolates.
- Specific genes associated with virulent bacteriophage acquisition were identified within these clusters.
Conclusions:
- The hypervirulent M1UK lineage of emm1 group A Streptococcus is increasingly dominating invasive infections in Canada.
- Genomic surveillance is essential for understanding the evolution and spread of virulent GAS strains.
- The acquisition of bacteriophages may contribute to the increased virulence and success of this lineage.
Related Concept Videos
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

